HCPCS Level IIdrugActive
J2267
Inj, mirikizumab-mrkz, 1 mg
BETOS: O1E
Effective: 2024-07-01
Referenced in 1 policies
Description
Injection, mirikizumab-mrkz, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Omvoh
Manufacturer
Eli Lilly and Company
HCPCS Dosage
1 MG
Billing Units
300.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.